← Leaderboards
Kevin J Anstrom
Univ Of North Carolina Chapel Hill
$80,353,737
Attributed
$152,897,930
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $55M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$152,897,930 · 13
By mechanism
U24$71,991,527 · 5
U10$60,593,456 · 2
UH3$10,305,288 · 1
U01$5,611,961 · 3
R01$3,463,319 · 1
UG3$932,379 · 1
Top collaborators
- Daniel B Mark12 shared
- Adrian Hernandez8 shared
- Anastasia Ivanova5 shared
- Fernando J Martinez5 shared
- Eric Eisenstein3 shared
- Hrishikesh Chakraborty2 shared
- Matthew Christopher Mauck2 shared
- Lisa Lavange1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Matthew I Milowsky$1,917,608
- Jonathan J Juliano$19,413,943
- Katharine L McGinigle$932,546
- Anastasia Ivanova$42,479,659
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentClinical TrialsDesignSiteNational Heart, Lung, And Blood InstituteData ManagementClinical ResearchData Coordinating CenterLeadershipRandomizedResearch InstituteHospitalizationFollow-UpResponseEnsureResearch PersonnelGuidelinesCardiovascular SystemCessation Of LifePharmaceutical PreparationsClinical Trials Data Monitoring CommitteesPublicationsReportingBase
Grant awards (53)
2/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis$952,993
U24 · FY2025 · HL · contact PI
2/2 Data Coordinating Center for the Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction Study (SPIRRIT-EX)$578,637
U24 · FY2025 · HL
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center$3,841,208
U24 · FY2024 · AR · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal$835,004
U24 · FY2024 · AT
2/2 Data Coordinating Center for the Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction Study (SPIRRIT-EX)$703,312
U24 · FY2024 · HL
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center$4,000,000
U24 · FY2023 · AR · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal$2,120,701
U24 · FY2023 · AT
Data, Modeling,and Coordination Center for PrecISE Network$4,322,714
U24 · FY2022 · HL
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal$2,439,270
U24 · FY2022 · AT
Trial to Assess Chelation Therapy 2 (TACT2) DCC Supplemental Bridge Funding$1,075,569
UH3 · FY2021 · AT · contact PI
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center$416,385
U24 · FY2021 · AR · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$1,893,898
UH3 · FY2020 · AT · contact PI
TRANSFORM-HF DCC$702,759
U01 · FY2020 · HL · contact PI
SPIRRIT-HFPEF - DCC$155,988
U01 · FY2020 · HL · contact PI
Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center$51,781,303
U24 · FY2019 · AR · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$1,594,889
UH3 · FY2019 · AT · contact PI
TRANSFORM-HF DCC$728,749
U01 · FY2019 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$700,505
UH3 · FY2019 · AT · contact PI
SPIRRIT-HFPEF - DCC$164,205
U01 · FY2019 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$5,662,534
U10 · FY2018 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$1,569,420
UH3 · FY2018 · AT · contact PI
TRANSFORM-HF DCC$785,473
U01 · FY2018 · HL · contact PI
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF$360,335
U01 · FY2018 · HL
SPIRRIT-HFPEF - DCC$266,134
U01 · FY2018 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$6,824,782
U10 · FY2017 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$1,959,035
UH3 · FY2017 · AT · contact PI
TRANSFORM-HF DCC$842,495
U01 · FY2017 · HL · contact PI
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF$360,316
U01 · FY2017 · HL
SPIRRIT-HFPEF - DCC$334,160
U01 · FY2017 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$5,400,716
U10 · FY2016 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$2,068,753
U10 · FY2016 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$1,511,972
UH3 · FY2016 · AT · contact PI
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)$879,760
R01 · FY2016 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$389,771
UG3 · FY2016 · AT · contact PI
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF$360,120
U01 · FY2016 · HL
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF$156,617
U01 · FY2016 · HL
Heart Failure Clinical Research Network Coordinating Center$5,447,198
U10 · FY2015 · HL · contact PI
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)$778,286
R01 · FY2015 · HL · contact PI
Trial to Assess Chelation Therapy 2 (TACT2) DCC$542,608
UG3 · FY2015 · AT · contact PI
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF$394,610
U01 · FY2015 · HL
Heart Failure Clinical Research Network Coordinating Center$5,197,907
U10 · FY2014 · HL · contact PI
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)$610,812
R01 · FY2014 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$4,745,879
U10 · FY2013 · HL · contact PI
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)$589,100
R01 · FY2013 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$445,000
U10 · FY2013 · HL · contact PI
Heart Failure Clinical Research Network Coordinating Center$2,648,537
U10 · FY2012 · HL · contact PI
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)$605,361
R01 · FY2012 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$5,094,337
U10 · FY2009 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$500,000
U10 · FY2009 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$5,011,589
U10 · FY2008 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$5,074,364
U10 · FY2007 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$5,186,417
U10 · FY2006 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$1,285,443
U10 · FY2005 · HL